FLS vs JAZZ · P/E 25, $7.01B cap vs P/E 1988, rev $2.28B
Flowserve Corporation (FLS) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Flowserve Corporation (FLS) is a specialty industrial machinery company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported FLS revenue for 2026-06-30 was $0. Net income was $180.7M. FLS currently screens at market cap $7.01B and trailing P/E 25.1.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
FLS currently screens at market cap $7.01B and trailing P/E 25.1. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the FLS and JAZZ stock pages for the full models.
Not investment advice.